CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to introduce its new Multiple Organ System Tissue Microarrays for histology researchers to study a wide range of biological processes and diseases across multiple org...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is pleased to announce the launch of its new line of Circulatory System Tissue Microarrays to the scientific community. This new product line offers researchers a powerful too...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to announce the launch of its new line of user-friendly Tissue Clearing Kits and Reagents. These innovative products are designed to help researchers achieve more det...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to announce the launch of its new Multicolor Immunofluorescence Staining Kits. These kits empower researchers to achieve high-quality staining of tissues and cells ut...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, proudly announces an extensive portfolio of Nervous System Tissue Microarrays designed to support neuroscience research. This comprehensive collection provides researchers wit...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is delighted to announce the addition of a new line of IHC Ancillaries to its product portfolio, including deparaffinators, retrievers and enzymes, washers and detergents, dil...

HighRun DataScience, a leading provider of data science solutions, has recently announced the launch of its comprehensive suite of statistical and data science services specifically designed to empower retail businesses of all sizes. Leveraging advanced technologies and a team...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the launch of its innovative line of Chromogenic Substrates for immunohistochemistry (IHC). These cutting-edge substrates offer superior signal sensitivity, long-t...

CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new services to study the Mechanistic Target of Rapamycin (mTOR) in diabetes and metabolism research. The mechanistic Target of Rapamycin is a serine/threonine pr...

CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its comprehensive research solutions for the scientific community to gain insights into glucose homeostasis. The company’s research team has developed several metabol...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the expansion of its portfolio to include a comprehensive line of Embedding Resins and Kits for electron and light microscopy. These kits offer a convenient and st...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the launch of its 3D Image Analysis Services for researchers, from data processing and analysis to custom report generation. Pathogenesis, prevention and treatment...

CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new services to study Anabolism in diabetes. The new solutions can help researchers to better understand the the synthesis of molecules. Metabolism is a series of...

CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new Catabolism research services, which offer researchers a comprehensive range of tools and resources to investigate the role of catabolism in the development an...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, announced the launch of its new 3D Tissue Imaging Services to researchers with comprehensive solutions for 3D imaging of tissues, including 3D Immunolabeling, Tissue Removal, 3D...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, announced the availability of its new services based on Single Molecule Fluorescence Imaging technology. This breakthrough technology enables scientists to study the behavior an...

CD BioSciences, a US-based CRO serving the global life science research community, has announced a series of new solutions for metabolic homeostasis, including Regulator Characterization, Mechanism Study, Phenotype Analysis, Animal Model Generation, and Therapy Development. Me...

CD BioSciences, a US-based CRO serving the global life science research community, has announced a series of new solutions on mitotic catastrophe, including Regulator Identification, Chemical Screening, Regulator Characterization, Cell Death Characterization, and Animal Model...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, introduced its new services based on super-resolution imaging technology to assist researchers in studying various cellular activities in cellular structures, such as DNA/RNA an...

CD BioSciences, a US-based CRO serving the global life science research community, has recently launched a suite of research solutions to support scientists studying of cell death, specifically Microautophagy, including Chemical Screening, Regulator Identification, Mechanism S...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has recently launched its new Time-Lapse Imaging services to assist scientists in a variety of projects, including the study of cell migration in chemotaxis assays or wound heal...